Freeline

About:

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Website: https://freeline.life

Twitter/X: FreelineLife

Top Investors: Innovate UK, Novo Holdings, Wellington Management, Acorn Bioventures, Eventide

Description:

Freeline is a clinical biotechnology company that develops transformative adeno-associated virus-vector-mediated systemic gene therapies. They use a designed AAV vector and capsid along with novel promoters and transgenes to deliver a functional copy of a therapeutic gene into human liver cells to express a functional level of the missing or dysfunctional protein into the patient’s bloodstream. Their development programs including clinical trials focus on developing products.

Total Funding Amount:

$302M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Stevenage, Herefordshire, United Kingdom

Founded Date:

2015-01-01

Contact Email:

contact(AT)freeline.life

Founders:

Amit Nathwani, Markus Hörer

Number of Employees:

251-500

Last Funding Date:

2022-03-10

IPO Status:

Delisted

© 2025 bioDAO.ai